Cns Net Cash Flow from Operations from 2010 to 2024

CNSP Stock  USD 0.38  0.01  2.70%   
Check Cns Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cns main balance sheet or income statement drivers, such as Interest Income of 34.9 K, Interest Expense of 14.1 K or Selling General Administrative of 3.8 M, as well as many exotic indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Price Book Value Ratio of 0.38. Cns financial statements analysis is a perfect complement when working with Cns Pharmaceuticals Valuation or Volatility modules.
  
This module can also supplement various Cns Pharmaceuticals Technical models . Check out the analysis of Cns Pharmaceuticals Correlation against competitors.
To learn how to invest in Cns Stock, please use our How to Invest in Cns Pharmaceuticals guide.

About Cns Pharmaceuticals Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Cns Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Cns Pharmaceuticals investors use historical funamental indicators, such as Cns Pharmaceuticals's Net Cash Flow from Operations, to determine how well the company is positioned to perform in the future. Although Cns Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Cns Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Cns Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Cns Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Cns Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company was incorporated in 2017 and is based in Houston, Texas. Cns Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 3 people.

Pair Trading with Cns Pharmaceuticals

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cns Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cns Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.

Moving together with Cns Stock

  0.74MBRX Moleculin Biotech Upward RallyPairCorr
  0.67MCRB Seres Therapeutics Financial Report 14th of May 2024 PairCorr

Moving against Cns Stock

  0.87MRK Merck Company Fiscal Quarter End 31st of March 2024 PairCorr
  0.84DNTH Dianthus Therapeutics Symbol ChangePairCorr
  0.83MGNX MacroGenics Financial Report 14th of May 2024 PairCorr
  0.67URGN UroGen Pharma Financial Report 9th of May 2024 PairCorr
  0.65EQ Equillium Financial Report 9th of May 2024 PairCorr
The ability to find closely correlated positions to Cns Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cns Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cns Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cns Pharmaceuticals to buy it.
The correlation of Cns Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cns Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cns Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cns Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Cns Pharmaceuticals is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Cns Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Cns Pharmaceuticals Stock. Highlighted below are key reports to facilitate an investment decision about Cns Pharmaceuticals Stock:
Check out the analysis of Cns Pharmaceuticals Correlation against competitors.
To learn how to invest in Cns Stock, please use our How to Invest in Cns Pharmaceuticals guide.
You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Complementary Tools for Cns Stock analysis

When running Cns Pharmaceuticals' price analysis, check to measure Cns Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cns Pharmaceuticals is operating at the current time. Most of Cns Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cns Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cns Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cns Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Is Cns Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cns Pharmaceuticals. If investors know Cns will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cns Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(7.60)
Return On Assets
(1.95)
Return On Equity
(5.60)
The market value of Cns Pharmaceuticals is measured differently than its book value, which is the value of Cns that is recorded on the company's balance sheet. Investors also form their own opinion of Cns Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Cns Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cns Pharmaceuticals' market value can be influenced by many factors that don't directly affect Cns Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cns Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cns Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cns Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.